Dr. Tristy S Shaw, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 520 N Prospect Ave, Suite 211, Redondo Beach, CA 90277 Phone: 310-406-2349 Fax: 310-406-8012 |
Darryl Leong, MD, MPH Pediatrics Medicare: Medicare Enrolled Practice Location: 2202 Curtis Ave, # B, Redondo Beach, CA 90278 Phone: 310-386-0459 |
Arjun Gowda, Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 514 N Prospect Ave, Redondo Beach, CA 90277 Phone: 310-937-8555 Fax: 310-937-8556 |
Dr. Cecily Julia Gallup, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 514 N Prospect Ave, Redondo Beach, CA 90277 Phone: 310-937-8555 Fax: 310-937-8556 |
Daniel Schmitz, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 514 N Prospect Ave Ste 103, Redondo Beach, CA 90277 Phone: 310-937-8555 Fax: 310-937-8556 |
Dr. Rita Tenenbaum, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 510 N. Prospect Ave.,, Suite 120, Redondo Beach, CA 90277 Phone: 310-406-0827 Fax: 310-406-8378 |
Juline Adelle Asamoah, Pediatrics Medicare: Medicare Enrolled Practice Location: 514 N Prospect Ave, Redondo Beach, CA 90277 Phone: 310-937-8555 Fax: 310-937-8556 |
News Archive
A new study provides compelling evidence that a simple tool can help predict which patients with cancer may be in their final year of life. The tool, known as the Surprise Question, was found to predict the risk of cancer death within one year better than factors such as cancer type or stage alone. This study will be presented at the upcoming 2015 Palliative Care in Oncology Symposium in Boston.
Persons who have developed positive attitudes towards life and aging are less likely to develop dementia finds a new study. Becca Levy from the Yale School of Public Health, USA, and colleagues have published the reports of this encouraging study in the latest issue of the journal PLOS ONE.
A protector for PTEN, a tumor-thwarting protein often missing in cancer cells, has emerged from research led by scientists at The University of Texas MD Anderson Cancer Center published online at Nature Cell Biology this week.
The Obama administration is proposing regulatory changes to clarify who is prohibited from owning a gun for mental health reasons and to tighten background checks. In the meantime, lawmakers consider increasing mental health funding after the Sandy Hook massacre.
Regulus Therapeutics Inc. announced today that the United States Patent and Trademark Office (USPTO) has allowed claims in U.S. Application Serial No. 11/977,506 covering methods of antagonizing miR-181a to regulate immune response. This patent is owned by Stanford University and licensed exclusively to Regulus. miR-181a has been shown to regulate the response of immune cells, such as T lymphocytes, to specific stimuli and modulation of miR-181a could lead to a novel treatment of inflammatory disease.
› Verified 6 days ago